Diagnos Inc. Announces Three-Year Contract Renewal with Optina Diagnostics Providing A Telemedicine Platform to Support Their Early Detection of Alzheimer's Disease Test
September 02, 2021 at 02:17 pm
DIAGNOS Inc. announced a contract renewal to provide its telemedicine platform based on CARA (Computer Assisted Retina Analysis) to Optina Diagnostics ("Optina") for an additional three-year period. Optina uses DIAGNOS' Cloud platform to upload images generated by the Optina -4C hyperspectral camera to be used with their awAIr Cerebral Amyloid Status test (for Research Use Only). Using the DIAGNOS CARA Cloud platform, the Optina's proprietary retinal images are processed, securely stored, and available to be shared and reviewed by healthcare professionals and clinics in various locations around the world. Optina benefits from the high throughput of the DIAGNOS CARA Cloud platform as well as the ease of use of the teleophthalmology platform currently used by doctors and other medical professionals.